Table of Content

1 Report Overview
1.1 Porcine Vaccines Definition
1.2 Market by Type
1.2.1 Global Porcine Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Other
1.3 Market Segment by Application
1.3.1 Global Porcine Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Porcine Vaccines Sales
2.1 Global Porcine Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Porcine Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Porcine Vaccines Revenue by Region
2.3.1 Global Porcine Vaccines Revenue by Region (2018-2024)
2.3.2 Global Porcine Vaccines Revenue by Region (2024-2034)
2.4 Global Porcine Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Porcine Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Porcine Vaccines Sales Quantity by Region
2.6.1 Global Porcine Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global Porcine Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Porcine Vaccines Sales Quantity by Manufacturers
3.1.1 Global Porcine Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Porcine Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Porcine Vaccines Sales in 2022
3.2 Global Porcine Vaccines Revenue by Manufacturers
3.2.1 Global Porcine Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Porcine Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Porcine Vaccines Revenue in 2022
3.3 Global Porcine Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Porcine Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Porcine Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Porcine Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Porcine Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Porcine Vaccines Sales Quantity by Type
4.1.1 Global Porcine Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Porcine Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Porcine Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Porcine Vaccines Revenue by Type
4.2.1 Global Porcine Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Porcine Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Porcine Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Porcine Vaccines Price by Type
4.3.1 Global Porcine Vaccines Price by Type (2018-2024)
4.3.2 Global Porcine Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Porcine Vaccines Sales Quantity by Application
5.1.1 Global Porcine Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Porcine Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Porcine Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Porcine Vaccines Revenue by Application
5.2.1 Global Porcine Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Porcine Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Porcine Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Porcine Vaccines Price by Application
5.3.1 Global Porcine Vaccines Price by Application (2018-2024)
5.3.2 Global Porcine Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Porcine Vaccines Sales by Company
6.1.1 North America Porcine Vaccines Revenue by Company (2018-2024)
6.1.2 North America Porcine Vaccines Sales Quantity by Company (2018-2024)
6.2 North America Porcine Vaccines Market Size by Type
6.2.1 North America Porcine Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Porcine Vaccines Revenue by Type (2018-2034)
6.3 North America Porcine Vaccines Market Size by Application
6.3.1 North America Porcine Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Porcine Vaccines Revenue by Application (2018-2034)
6.4 North America Porcine Vaccines Market Size by Country
6.4.1 North America Porcine Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Porcine Vaccines Revenue by Country (2018-2034)
6.4.3 North America Porcine Vaccines Sales Quantity by Country (2018-2034)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe Porcine Vaccines Sales by Company
7.1.1 Europe Porcine Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe Porcine Vaccines Revenue by Company (2018-2024)
7.2 Europe Porcine Vaccines Market Size by Type
7.2.1 Europe Porcine Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Porcine Vaccines Revenue by Type (2018-2034)
7.3 Europe Porcine Vaccines Market Size by Application
7.3.1 Europe Porcine Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Porcine Vaccines Revenue by Application (2018-2034)
7.4 Europe Porcine Vaccines Market Size by Country
7.4.1 Europe Porcine Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Porcine Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Porcine Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 UK
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Porcine Vaccines Sales by Company
8.1.1 China Porcine Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China Porcine Vaccines Revenue by Company (2018-2024)
8.2 China Porcine Vaccines Market Size by Type
8.2.1 China Porcine Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Porcine Vaccines Revenue by Type (2018-2034)
8.3 China Porcine Vaccines Market Size by Application
8.3.1 China Porcine Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Porcine Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Porcine Vaccines Sales by Company
9.1.1 APAC Porcine Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC Porcine Vaccines Revenue by Company (2018-2024)
9.2 APAC Porcine Vaccines Market Size by Type
9.2.1 APAC Porcine Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Porcine Vaccines Revenue by Type (2018-2034)
9.3 APAC Porcine Vaccines Market Size by Application
9.3.1 APAC Porcine Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Porcine Vaccines Revenue by Application (2018-2034)
9.4 APAC Porcine Vaccines Market Size by Region
9.4.1 APAC Porcine Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Porcine Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Porcine Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Porcine Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Porcine Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Porcine Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Porcine Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Porcine Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Porcine Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Porcine Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Porcine Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Porcine Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Porcine Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Porcine Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Porcine Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Porcine Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Merck Porcine Vaccines Products and Services
11.1.5 Merck Porcine Vaccines SWOT Analysis
11.1.6 Merck Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Boehringer Ingelheim Porcine Vaccines Products and Services
11.2.5 Boehringer Ingelheim Porcine Vaccines SWOT Analysis
11.2.6 Boehringer Ingelheim Recent Developments
11.3 Jinyu Bio-Technology
11.3.1 Jinyu Bio-Technology Company Information
11.3.2 Jinyu Bio-Technology Overview
11.3.3 Jinyu Bio-Technology Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Jinyu Bio-Technology Porcine Vaccines Products and Services
11.3.5 Jinyu Bio-Technology Porcine Vaccines SWOT Analysis
11.3.6 Jinyu Bio-Technology Recent Developments
11.4 CAHIC
11.4.1 CAHIC Company Information
11.4.2 CAHIC Overview
11.4.3 CAHIC Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 CAHIC Porcine Vaccines Products and Services
11.4.5 CAHIC Porcine Vaccines SWOT Analysis
11.4.6 CAHIC Recent Developments
11.5 Tecon
11.5.1 Tecon Company Information
11.5.2 Tecon Overview
11.5.3 Tecon Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Tecon Porcine Vaccines Products and Services
11.5.5 Tecon Porcine Vaccines SWOT Analysis
11.5.6 Tecon Recent Developments
11.6 Zoetis
11.6.1 Zoetis Company Information
11.6.2 Zoetis Overview
11.6.3 Zoetis Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Zoetis Porcine Vaccines Products and Services
11.6.5 Zoetis Porcine Vaccines SWOT Analysis
11.6.6 Zoetis Recent Developments
11.7 Ceva
11.7.1 Ceva Company Information
11.7.2 Ceva Overview
11.7.3 Ceva Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Ceva Porcine Vaccines Products and Services
11.7.5 Ceva Porcine Vaccines SWOT Analysis
11.7.6 Ceva Recent Developments
11.8 Hile Bio
11.8.1 Hile Bio Company Information
11.8.2 Hile Bio Overview
11.8.3 Hile Bio Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Hile Bio Porcine Vaccines Products and Services
11.8.5 Hile Bio Porcine Vaccines SWOT Analysis
11.8.6 Hile Bio Recent Developments
11.9 Chopper Biology
11.9.1 Chopper Biology Company Information
11.9.2 Chopper Biology Overview
11.9.3 Chopper Biology Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Chopper Biology Porcine Vaccines Products and Services
11.9.5 Chopper Biology Porcine Vaccines SWOT Analysis
11.9.6 Chopper Biology Recent Developments
11.10 WINSUN
11.10.1 WINSUN Company Information
11.10.2 WINSUN Overview
11.10.3 WINSUN Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 WINSUN Porcine Vaccines Products and Services
11.10.5 WINSUN Porcine Vaccines SWOT Analysis
11.10.6 WINSUN Recent Developments
11.11 Hipra
11.11.1 Hipra Company Information
11.11.2 Hipra Overview
11.11.3 Hipra Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Hipra Porcine Vaccines Products and Services
11.11.5 Hipra Recent Developments
11.12 Ringpu Biology
11.12.1 Ringpu Biology Company Information
11.12.2 Ringpu Biology Overview
11.12.3 Ringpu Biology Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Ringpu Biology Porcine Vaccines Products and Services
11.12.5 Ringpu Biology Recent Developments
11.13 ChengDu Tecbond
11.13.1 ChengDu Tecbond Company Information
11.13.2 ChengDu Tecbond Overview
11.13.3 ChengDu Tecbond Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 ChengDu Tecbond Porcine Vaccines Products and Services
11.13.5 ChengDu Tecbond Recent Developments
11.14 DHN
11.14.1 DHN Company Information
11.14.2 DHN Overview
11.14.3 DHN Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 DHN Porcine Vaccines Products and Services
11.14.5 DHN Recent Developments
11.15 CAVAC
11.15.1 CAVAC Company Information
11.15.2 CAVAC Overview
11.15.3 CAVAC Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 CAVAC Porcine Vaccines Products and Services
11.15.5 CAVAC Recent Developments
11.16 Virbac
11.16.1 Virbac Company Information
11.16.2 Virbac Overview
11.16.3 Virbac Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.16.4 Virbac Porcine Vaccines Products and Services
11.16.5 Virbac Recent Developments
11.17 HVRI
11.17.1 HVRI Company Information
11.17.2 HVRI Overview
11.17.3 HVRI Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.17.4 HVRI Porcine Vaccines Products and Services
11.17.5 HVRI Recent Developments
11.18 Bioveta
11.18.1 Bioveta Company Information
11.18.2 Bioveta Overview
11.18.3 Bioveta Porcine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.18.4 Bioveta Porcine Vaccines Products and Services
11.18.5 Bioveta Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Porcine Vaccines Value Chain Analysis
12.2 Porcine Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Porcine Vaccines Production Mode & Process
12.4 Porcine Vaccines Sales and Marketing
12.4.1 Porcine Vaccines Sales Channels
12.4.2 Porcine Vaccines Distributors
12.5 Porcine Vaccines Customers
13 Market Dynamics
13.1 Porcine Vaccines Industry Trends
13.2 Porcine Vaccines Market Drivers
13.3 Porcine Vaccines Market Challenges
13.4 Porcine Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Porcine Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of CSF Vaccines
Table 3. Major Manufacturers of FMD Vaccines
Table 4. Major Manufacturers of Porcine Circovirus Vaccines
Table 5. Major Manufacturers of PRRS Vaccines
Table 6. Major Manufacturers of Other
Table 7. Global Porcine Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Porcine Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Porcine Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Porcine Vaccines Revenue Market Share by Region (2018-2024)
Table 11. Global Porcine Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Porcine Vaccines Revenue Market Share by Region (2024-2034)
Table 13. Global Porcine Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (Units)
Table 14. Global Porcine Vaccines Sales by Region (2018-2024) & (Units)
Table 15. Global Porcine Vaccines Sales Market Share by Region (2018-2024)
Table 16. Global Porcine Vaccines Sales by Region (2024-2034) & (Units)
Table 17. Global Porcine Vaccines Sales Market Share by Region (2024-2034)
Table 18. Global Porcine Vaccines Sales Quantity by Manufacturers (2018-2024) & (Units)
Table 19. Global Porcine Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 20. Global Porcine Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Porcine Vaccines Revenue Share by Manufacturers (2018-2024)
Table 22. Global Porcine Vaccines Price by Manufacturers 2018-2024 (K USD/Unit)
Table 23. Global Key Players of Porcine Vaccines, Industry Ranking, 2021 VS 2022
Table 24. Global Porcine Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Porcine Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Porcine Vaccines as of 2022)
Table 26. Global Key Manufacturers of Porcine Vaccines, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Porcine Vaccines, Product Offered and Application
Table 28. Global Key Manufacturers of Porcine Vaccines, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Porcine Vaccines Sales Quantity by Type (2018-2024) & (Units)
Table 31. Global Porcine Vaccines Sales Quantity by Type (2024-2034) & (Units)
Table 32. Global Porcine Vaccines Sales Quantity Share by Type (2018-2024)
Table 33. Global Porcine Vaccines Sales Quantity Share by Type (2024-2034)
Table 34. Global Porcine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Porcine Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Porcine Vaccines Revenue Share by Type (2018-2024)
Table 37. Global Porcine Vaccines Revenue Share by Type (2024-2034)
Table 38. Porcine Vaccines Price by Type (2018-2024) & (K USD/Unit)
Table 39. Global Porcine Vaccines Price Forecast by Type (2024-2034) & (K USD/Unit)
Table 40. Global Porcine Vaccines Sales Quantity by Application (2018-2024) & (Units)
Table 41. Global Porcine Vaccines Sales Quantity by Application (2024-2034) & (Units)
Table 42. Global Porcine Vaccines Sales Quantity Share by Application (2018-2024)
Table 43. Global Porcine Vaccines Sales Quantity Share by Application (2024-2034)
Table 44. Global Porcine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Porcine Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Porcine Vaccines Revenue Share by Application (2018-2024)
Table 47. Global Porcine Vaccines Revenue Share by Application (2024-2034)
Table 48. Porcine Vaccines Price by Application (2018-2024) & (K USD/Unit)
Table 49. Global Porcine Vaccines Price Forecast by Application (2024-2034) & (K USD/Unit)
Table 50. North America Porcine Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 51. North America Porcine Vaccines Sales Quantity by Company (2018-2024) & (Units)
Table 52. North America Porcine Vaccines Sales Quantity by Type (2018-2024) & (Units)
Table 53. North America Porcine Vaccines Sales Quantity by Type (2024-2034) & (Units)
Table 54. North America Porcine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 55. North America Porcine Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Porcine Vaccines Sales Quantity by Application (2018-2024) & (Units)
Table 57. North America Porcine Vaccines Sales Quantity by Application (2024-2034) & (Units)
Table 58. North America Porcine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 59. North America Porcine Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Porcine Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 61. North America Porcine Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 62. North America Porcine Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Porcine Vaccines Sales Quantity by Country (2018-2024) & (Units)
Table 64. North America Porcine Vaccines Sales Quantity by Country (2024-2034) & (Units)
Table 65. Europe Porcine Vaccines Sales Quantity by Company (2018-2024) & (Units)
Table 66. Europe Porcine Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 67. Europe Porcine Vaccines Sales Quantity by Type (2018-2024) & (Units)
Table 68. Europe Porcine Vaccines Sales Quantity by Type (2024-2034) & (Units)
Table 69. Europe Porcine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 70. Europe Porcine Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Porcine Vaccines Sales Quantity by Application (2018-2024) & (Units)
Table 72. Europe Porcine Vaccines Sales Quantity by Application (2024-2034) & (Units)
Table 73. Europe Porcine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 74. Europe Porcine Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Porcine Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 76. Europe Porcine Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 77. Europe Porcine Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Porcine Vaccines Sales Quantity by Country (2018-2024) & (Units)
Table 79. Europe Porcine Vaccines Sales Quantity by Country (2024-2034) & (Units)
Table 80. China Porcine Vaccines Sales Quantity by Company (2018-2024) & (Units)
Table 81. China Porcine Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 82. China Porcine Vaccines Sales Quantity by Type (2018-2024) & (Units)
Table 83. China Porcine Vaccines Sales Quantity by Type (2024-2034) & (Units)
Table 84. China Porcine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 85. China Porcine Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Porcine Vaccines Sales Quantity by Application (2018-2024) & (Units)
Table 87. China Porcine Vaccines Sales Quantity by Application (2024-2034) & (Units)
Table 88. China Porcine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 89. China Porcine Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Porcine Vaccines Sales Quantity by Company (2018-2024) & (Units)
Table 91. APAC Porcine Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 92. APAC Porcine Vaccines Sales Quantity by Type (2018-2024) & (Units)
Table 93. APAC Porcine Vaccines Sales Quantity by Type (2024-2034) & (Units)
Table 94. APAC Porcine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 95. APAC Porcine Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Porcine Vaccines Sales Quantity by Application (2018-2024) & (Units)
Table 97. APAC Porcine Vaccines Sales Quantity by Application (2024-2034) & (Units)
Table 98. APAC Porcine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 99. APAC Porcine Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Porcine Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 101. APAC Porcine Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 102. APAC Porcine Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Porcine Vaccines Sales Quantity by Region (2018-2024) & (Units)
Table 104. APAC Porcine Vaccines Sales Quantity by Region (2024-2034) & (Units)
Table 105. Middle East, Africa and Latin America Porcine Vaccines Sales Quantity by Company (2018-2024) & (Units)
Table 106. Middle East, Africa and Latin America Porcine Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Porcine Vaccines Sales Quantity by Type (2018-2024) & (Units)
Table 108. Middle East, Africa and Latin America Porcine Vaccines Sales Quantity by Type (2024-2034) & (Units)
Table 109. Middle East, Africa and Latin America Porcine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Porcine Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Porcine Vaccines Sales Quantity by Application (2018-2024) & (Units)
Table 112. Middle East, Africa and Latin America Porcine Vaccines Sales Quantity by Application (2024-2034) & (Units)
Table 113. Middle East, Africa and Latin America Porcine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Porcine Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Porcine Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Porcine Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 117. Middle East, Africa and Latin America Porcine Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Porcine Vaccines Sales Quantity by Country (2018-2024) & (Units)
Table 119. Middle East, Africa and Latin America Porcine Vaccines Sales Quantity by Country (2024-2034) & (Units)
Table 120. Merck Company Information
Table 121. Merck Description and Overview
Table 122. Merck Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 123. Merck Porcine Vaccines Product and Services
Table 124. Merck Porcine Vaccines SWOT Analysis
Table 125. Merck Recent Developments
Table 126. Boehringer Ingelheim Company Information
Table 127. Boehringer Ingelheim Description and Overview
Table 128. Boehringer Ingelheim Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 129. Boehringer Ingelheim Porcine Vaccines Product and Services
Table 130. Boehringer Ingelheim Porcine Vaccines SWOT Analysis
Table 131. Boehringer Ingelheim Recent Developments
Table 132. Jinyu Bio-Technology Company Information
Table 133. Jinyu Bio-Technology Description and Overview
Table 134. Jinyu Bio-Technology Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 135. Jinyu Bio-Technology Porcine Vaccines Product and Services
Table 136. Jinyu Bio-Technology Porcine Vaccines SWOT Analysis
Table 137. Jinyu Bio-Technology Recent Developments
Table 138. CAHIC Company Information
Table 139. CAHIC Description and Overview
Table 140. CAHIC Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 141. CAHIC Porcine Vaccines Product and Services
Table 142. CAHIC Porcine Vaccines SWOT Analysis
Table 143. CAHIC Recent Developments
Table 144. Tecon Company Information
Table 145. Tecon Description and Overview
Table 146. Tecon Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 147. Tecon Porcine Vaccines Product and Services
Table 148. Tecon Porcine Vaccines SWOT Analysis
Table 149. Tecon Recent Developments
Table 150. Zoetis Company Information
Table 151. Zoetis Description and Overview
Table 152. Zoetis Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 153. Zoetis Porcine Vaccines Product and Services
Table 154. Zoetis Porcine Vaccines SWOT Analysis
Table 155. Zoetis Recent Developments
Table 156. Ceva Company Information
Table 157. Ceva Description and Overview
Table 158. Ceva Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 159. Ceva Porcine Vaccines Product and Services
Table 160. Ceva Porcine Vaccines SWOT Analysis
Table 161. Ceva Recent Developments
Table 162. Hile Bio Company Information
Table 163. Hile Bio Description and Overview
Table 164. Hile Bio Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 165. Hile Bio Porcine Vaccines Product and Services
Table 166. Hile Bio Porcine Vaccines SWOT Analysis
Table 167. Hile Bio Recent Developments
Table 168. Chopper Biology Company Information
Table 169. Chopper Biology Description and Overview
Table 170. Chopper Biology Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 171. Chopper Biology Porcine Vaccines Product and Services
Table 172. Chopper Biology Porcine Vaccines SWOT Analysis
Table 173. Chopper Biology Recent Developments
Table 174. WINSUN Company Information
Table 175. WINSUN Description and Overview
Table 176. WINSUN Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 177. WINSUN Porcine Vaccines Product and Services
Table 178. WINSUN Porcine Vaccines SWOT Analysis
Table 179. WINSUN Recent Developments
Table 180. Hipra Company Information
Table 181. Hipra Description and Overview
Table 182. Hipra Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 183. Hipra Porcine Vaccines Product and Services
Table 184. Hipra Recent Developments
Table 185. Ringpu Biology Company Information
Table 186. Ringpu Biology Description and Overview
Table 187. Ringpu Biology Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 188. Ringpu Biology Porcine Vaccines Product and Services
Table 189. Ringpu Biology Recent Developments
Table 190. ChengDu Tecbond Company Information
Table 191. ChengDu Tecbond Description and Overview
Table 192. ChengDu Tecbond Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 193. ChengDu Tecbond Porcine Vaccines Product and Services
Table 194. ChengDu Tecbond Recent Developments
Table 195. DHN Company Information
Table 196. DHN Description and Overview
Table 197. DHN Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 198. DHN Porcine Vaccines Product and Services
Table 199. DHN Recent Developments
Table 200. CAVAC Company Information
Table 201. CAVAC Description and Overview
Table 202. CAVAC Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 203. CAVAC Porcine Vaccines Product and Services
Table 204. CAVAC Recent Developments
Table 205. Virbac Company Information
Table 206. Virbac Description and Overview
Table 207. Virbac Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 208. Virbac Porcine Vaccines Product and Services
Table 209. Virbac Recent Developments
Table 210. HVRI Company Information
Table 211. HVRI Description and Overview
Table 212. HVRI Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 213. HVRI Porcine Vaccines Product and Services
Table 214. HVRI Recent Developments
Table 215. Bioveta Company Information
Table 216. Bioveta Description and Overview
Table 217. Bioveta Porcine Vaccines Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (K USD/Unit) and Gross Margin (2018-2024)
Table 218. Bioveta Porcine Vaccines Product and Services
Table 219. Bioveta Recent Developments
Table 220. Key Raw Materials Lists
Table 221. Raw Materials Key Suppliers Lists
Table 222. Porcine Vaccines Distributors List
Table 223. Porcine Vaccines Customers List
Table 224. Porcine Vaccines Market Trends
Table 225. Porcine Vaccines Market Drivers
Table 226. Porcine Vaccines Market Challenges
Table 227. Porcine Vaccines Market Restraints
Table 228. Research Programs/Design for This Report
Table 229. Key Data Information from Secondary Sources
Table 230. Key Data Information from Primary Sources
List of Figures
Figure 1. Porcine Vaccines Product Picture
Figure 2. Global Porcine Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Porcine Vaccines Market Share by Type in 2022 & 2034
Figure 4. CSF Vaccines Product Picture
Figure 5. FMD Vaccines Product Picture
Figure 6. Porcine Circovirus Vaccines Product Picture
Figure 7. PRRS Vaccines Product Picture
Figure 8. Other Product Picture
Figure 9. Global Porcine Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 10. Global Porcine Vaccines Market Share by Application in 2022 & 2034
Figure 11. Government Tender
Figure 12. Market Sales
Figure 13. Porcine Vaccines Report Years Considered
Figure 14. Global Porcine Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Porcine Vaccines Revenue 2018-2034 (US$ Million)
Figure 16. Global Porcine Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 17. Global Porcine Vaccines Sales Quantity 2018-2034 (Units)
Figure 18. Global Porcine Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 19. Global Porcine Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Porcine Vaccines Sales Quantity YoY (2018-2034) & (Units)
Figure 21. North America Porcine Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Porcine Vaccines Sales Quantity YoY (2018-2034) & (Units)
Figure 23. Europe Porcine Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Porcine Vaccines Sales Quantity YoY (2018-2034) & (Units)
Figure 25. China Porcine Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Porcine Vaccines Sales Quantity YoY (2018-2034) & (Units)
Figure 27. APAC Porcine Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Porcine Vaccines Sales Quantity YoY (2018-2034) & (Units)
Figure 29. Middle East, Africa and Latin America Porcine Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Porcine Vaccines Sales Quantity in 2022
Figure 31. The Top 10 and Top 5 Players Market Share by Porcine Vaccines Revenue in 2022
Figure 32. Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Porcine Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Porcine Vaccines Revenue Market Share by Type (2018-2034)
Figure 35. Global Porcine Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Porcine Vaccines Revenue Market Share by Application (2018-2034)
Figure 37. North America Porcine Vaccines Revenue Market Share by Company in 2022
Figure 38. North America Porcine Vaccines Sales Quantity Market Share by Company in 2022
Figure 39. North America Porcine Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Porcine Vaccines Revenue Market Share by Type (2018-2034)
Figure 41. North America Porcine Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Porcine Vaccines Revenue Market Share by Application (2018-2034)
Figure 43. North America Porcine Vaccines Revenue Share by Country (2018-2034)
Figure 44. North America Porcine Vaccines Sales Quantity Share by Country (2018-2034)
Figure 45. the United States Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Porcine Vaccines Sales Quantity Market Share by Company in 2022
Figure 48. Europe Porcine Vaccines Revenue Market Share by Company in 2022
Figure 49. Europe Porcine Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Porcine Vaccines Revenue Market Share by Type (2018-2034)
Figure 51. Europe Porcine Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Porcine Vaccines Revenue Market Share by Application (2018-2034)
Figure 53. Europe Porcine Vaccines Revenue Share by Country (2018-2034)
Figure 54. Europe Porcine Vaccines Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 56. France Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. UK Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 60. China Porcine Vaccines Sales Quantity Market Share by Company in 2022
Figure 61. China Porcine Vaccines Revenue Market Share by Company in 2022
Figure 62. China Porcine Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Porcine Vaccines Revenue Market Share by Type (2018-2034)
Figure 64. China Porcine Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Porcine Vaccines Revenue Market Share by Application (2018-2034)
Figure 66. APAC Porcine Vaccines Sales Quantity Market Share by Company in 2022
Figure 67. APAC Porcine Vaccines Revenue Market Share by Company in 2022
Figure 68. APAC Porcine Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Porcine Vaccines Revenue Market Share by Type (2018-2034)
Figure 70. APAC Porcine Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Porcine Vaccines Revenue Market Share by Application (2018-2034)
Figure 72. APAC Porcine Vaccines Revenue Share by Region (2018-2034)
Figure 73. APAC Porcine Vaccines Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 78. India Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Porcine Vaccines Sales Quantity Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Porcine Vaccines Revenue Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Porcine Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Porcine Vaccines Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Porcine Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Porcine Vaccines Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Porcine Vaccines Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Porcine Vaccines Revenue Share by Country (2018-2034)
Figure 87. Brazil Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Porcine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 92. Porcine Vaccines Value Chain
Figure 93. Porcine Vaccines Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed